Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links

Mol Psychiatry. 2014 Oct;19(10):1054. doi: 10.1038/mp.2014.25. Epub 2014 Mar 25.

Authors

M J Titulaer¹, J Dalmau²

Affiliations

¹ 1] Department of Neurology at Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain [2] Erasmus Medical Center, Department of Neurology, Rotterdam, The Netherlands.
² 1] Department of Neurology at Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain [2] Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

PMID: 24662926
DOI: 10.1038/mp.2014.25

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Autoantibodies / blood*
Blood-Brain Barrier / metabolism*
Female
Humans
Male
Mood Disorders / metabolism*
Parkinson Disease / metabolism*
Receptors, N-Methyl-D-Aspartate / immunology*
Schizophrenia / metabolism*

Substances

Autoantibodies
Receptors, N-Methyl-D-Aspartate

Grants and funding

R01NS077851/NS/NINDS NIH HHS/United States